ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Ohio State to study center expansion.

September 26, 2003

One In 8 Survivors Report Suicidal Thoughts, Attempts

August 25, 2006

Price Increase

July 22, 1983

NCI To Seek Cancer Act Changes On Center Grant Limits

April 9, 1976

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992